A study to assess the safety and efficacy of full dose of Sofosbuvir and Daclatasvir in ESRD patients on Haemodialysis at GMC Anantnag. (2025). Vascular and Endovascular Review, 8(5s), 121-127. http://verjournal.com/index.php/ver/article/view/442